Research And Diagnostic Systems, Inc.
Minneapolis, MN Part of Bio-Techne Corporation
- UEI
- WAYSQU5HJYT9
- CAGE
- 6S541
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, BIO-Techne Corporation, ranks #61 in NAICS 325414
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
RDJKATCM39L5
-
- Wallingford, CT D29BGJJXMMS4
-
-
Parent
RDJKATCM39L5
- SAM.gov registration date
- Physical address
- 614 McKinley Pl NE, Minneapolis, MN 55413, USA
- Website
- rndsystems.com
- Founded
- 1985
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $87,937 |
| FY2024 | $89,487 |
| FY2023 | $133,075 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| The Charles Stark Draper Laboratory, Inc. | 75A50123C00042 | $30,614 | |
| The Charles Stark Draper Laboratory, Inc. | 75A50123C00042 | $35,945 | |
| University Of California, San Diego | 75N93024C00022 | $54,950 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Rapid non-viral platform for generation of genetically modified t cells for therapy | National Cancer Institute (NIH) | $1,617,646 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Abcam Inc. | Waltham, MA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Bio-Techne Sales Corporation | Minneapolis, MN | 325414 Biological Product (except Diagnostic) Manufacturing |
| Avanti Polar Lipids, LLC | Alabaster, AL | 325412 Pharmaceutical Preparation Manufacturing |
| Biolegend, Inc. | San Diego, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Takara Bio Usa, Inc. | San Jose, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Research And Diagnostic Systems, Inc., doing business as R&D Systems, is a for-profit manufacturer of biological research materials headquartered in Minneapolis, Minnesota. The company is a subsidiary of Bio-Techne Corporation and specializes in producing high-quality research reagents, proteins, antibodies, and laboratory supplies for biomedical research. R&D Systems has established itself as a critical supplier to numerous federal agencies, particularly within the National Institutes of Health (NIH) ecosystem, providing specialized scientific materials that support critical research across various medical and scientific disciplines.
Through its federal contract awards, R&D Systems has consistently provided a diverse range of biological and research-related products to multiple federal agencies. These products include recombinant human proteins, neurotrophic factors, ELISA kits, cytokine assays, fetal bovine serum, antibodies, and specialized research reagents. The company has been awarded contracts from agencies such as the National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Center for Advancing Translational Sciences, NIH Clinical Center, and others. Notably, many of these contracts have supported COVID-19 research, infectious disease studies, and translational science initiatives. All of the company's federal contract awards have been non-set-aside purchases, indicating open competition, and have ranged in value from approximately $10,000 to over $445,000, demonstrating the company's ability to provide both small and relatively large research supply orders.
R&D Systems holds a significant Blanket Purchase Agreement (BPA) with the Office of Logistics and Acquisition Operations, valued at $10,000,000 with a performance period through September 30, 2025. This single-award BPA enables the company to provide comprehensive biological materials, laboratory supplies, chemicals, blood products, and media items supporting biomedical research across multiple NIH institutes. The BPA allows for flexible task order fulfillment across critical research domains, including infectious diseases, cancer research, and translational science. Additionally, the company has engaged in subcontract work, including providing technical support to entities like The Charles Stark Draper Laboratory and supplying high-quality reagents and analytical kits to research institutions such as the University of California, San Diego, further demonstrating its versatility in supporting scientific research infrastructure.
Quick answers
Is Research And Diagnostic Systems, Inc. registered in SAM.gov?
Yes. Research And Diagnostic Systems, Inc.'s SAM.gov registration is active through January 2, 2027.
How much has Research And Diagnostic Systems, Inc. received in federal contracts?
Federal contracts obligated $87,937 to Research And Diagnostic Systems, Inc. in fiscal year 2025 and $310,499 in fiscal years 2023 through 2027.
How does Research And Diagnostic Systems, Inc. rank among federal contractors?
Research And Diagnostic Systems, Inc.'s parent company, BIO-Techne Corporation, ranked #61 in NAICS 325414 in FY2025.
What is Research And Diagnostic Systems, Inc.'s most recent federal award?
Research And Diagnostic Systems, Inc.'s most recent federal contract award is Recombinant human NT-3 protein, glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor… (140D0425P0179), from Interior Business Center (DO), on September 22, 2025.
On GovTribe
See Research And Diagnostic Systems, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors